Navigation Links
Rumors Dispelled Over Univision Talent Fernando Del Rincon's Cancer Diagnosis Being Fabricated
Date:7/8/2008

Elvia Barboa, Chief Executive Officer of PADRES Contra El Cancer (PADRES) issues a statement dispelling rumors their National Spokesperson Fernando

Del Rincon lied about his cancer treatment

LOS ANGELES, July 8 /PRNewswire/ -- In response to media reports suggesting that Univision's Fernando Del Rincon's cancer diagnosis was fabricated in order to draw media attention to himself, PADRES CEO, Elvia Barboa, M.A., found it imperative to issue the following statement to dispel such potentially libelous remarks:

"PADRES' responsibility is to ensure that accurate information is disseminated as it relates to the organization and its representatives. With respect to Fernando Del Rincon, the fact remains that he was diagnosed with bladder cancer in May 2008 and, fortunately, underwent a successful surgery that removed his tumor."

The rumors have caused concern for PADRES in particular because Del Rincon serves as one of its national spokespersons. PADRES Contra El Cancer is an organization committed to improving the quality of life for Latino children with cancer and their families. Most importantly, PADRES served as an integral part in Del Rincon's entire diagnosis and treatment.

According to Ms. Barboa, "PADRES supported Fernando with the same care, compassion and patient navigation provided to any family who has a child with cancer. PADRES helped Fernando understand his tests, diagnosis and treatment options; helped him secure a second opinion; helped him navigate the complex healthcare system; and most importantly, offered him much-needed emotional support. PADRES stood beside and continues to stand by him every step of the way."

Ms. Barboa disclosed that Fernando's choice to make public his diagnosis on May 31, 2008 at the PADRES' 5K Charity Run/Walk in Los Angeles stemmed from three reasons: 1) to encourage others to have annual health exams to prevent any serious disease; 2) to instill strength and hope in families to fight tenaciously for their children undergoing cancer treatment; and 3) to announce he would author a book reflecting on his emotional experience and struggles during his cancer process.

"If media outlets print inaccurate and misleading information about Fernando Del Rincon's cancer diagnosis, then such may indirectly discredit PADRES Contra El Cancer and its 23 years of advocacy on behalf of the pediatric cancer community. PADRES has been fortunate to work with many families and celebrities. Likewise, we are aware that often times the truth can unfortunately be distorted. PADRES remains honored and privileged to have Fernando Del Rincon serve as our spokesperson," concluded Ms. Barboa.

About PADRES:

PADRES Contra El Cancer (PADRES) is an organization committed to improving the quality of life for Latino children with cancer and their families. PADRES programs, activities and services, while primarily oriented to the Latino community, serve childhood cancer patients from ALL races and ethnic origins. No family is turned away.


'/>"/>
SOURCE PADRES Contra El Cancer
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
2. Video: Colon Cancer Myths Dispelled!
3. Eva Longoria Parker Participates in 5k Run/Walk to Raise Money for Children With Cancer and Offers Support to Univision Talent Fernando Del Rincons Cancer Diagnosis
4. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
5. Quincy Jones Lends Time and Talent to Support Red Cross Relief Efforts In China and Myanmar
6. Research talent wins national Innovation in Nursing award
7. Discover Talent Management Best Practices June 4-6 -- Registration Ends Friday
8. Retooling Talent Management Approaches to Find, Grow & Retain Tomorrows Leaders
9. Talent Shortage Emerges as No. 1 Employer Concern: Deloitte/ISCEBS
10. Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams
11. World class technology and talent battle cancer at the Centenary Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... Doctor C LLC, a company based out of Arizona that ... continue the marketing and distribution of its product, The Right C. , The Right ... absorption than traditional vitamin C supplements. At the trade show, Doctor C had the ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company based ... school-aged children since the holiday season. , “It happens every year around this ... hugs and taking photos, which is the head-to-head gateway that lice need to spread.” ...
(Date:1/20/2017)... ... , ... International Protein, a company based out of Australia that focuses on ... ECRM trade show in Hilton Head, SC. , International Protein was founded by ... line of products that would elevate her fitness regime. At this ECRM trade show, ...
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece ... “Mary Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda ... women who had little knowledge of the female characters portrayed in the Holy Bible. ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... Research and Markets has announced the ... Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type ... (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" report ... ... market segments, especially clinical lab testing, which has evolved as ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... NEW YORK , Jan. 20, 2017  Faruqi & ... in KemPharm, Inc. ("KemPharm" or the "Company") (NASDAQ: ... against the Company and certain officers and directors and underwriters ... "IPO") to seek the role of lead plaintiff. ... District Court for Johnson County ...
Breaking Medicine Technology: